Haemonetics Corp (HAE)

EBITDA Margin

19.32%

TTM · Period ending:

HAE logo

HAE EBITDA Margin

Latest reported19.32%
HAE TTM EBITDA Margin (100.00% → 19.32%)
High-resolution chart · PNG

HAE ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Haemonetics Corp EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
33.0749%
27.5373%
20.2412%
19.647%
20.4849%
21.0989%
20.8142%
21.0583%
21.4823%
20.0213%
27.1147%
26.3967%
24.7913%
24.7726%
18.0818%
18.005%
18.6039%
19.8192%
20.9498%
22.674%
23.5521%
24.2272%
25.2174%
25.1012%
25.2706%
25.2668%
25.784%
25.9086%
25.6714%
25.161%
24.6898%
24.1409%
23.5632%
23.3472%
23.0174%
22.3934%
21.645%
20.8735%
39.1771%
58.8889%
79.5699%
100%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.